| Model Number |
H7493942816500 |
| Medical Device Problem Codes |
Material Rupture (1546); Failure to Unfold or Unwrap (1669); Device Dislodged or Dislocated (2923)
|
| Health Effect - Clinical Code |
Hypoxia (1918)
|
| Date of Event |
07/01/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported vis medsun (b)(4) that balloon rupture occurred requiring additional surgery.The patient presented for a right heart percutaneous, patent ductus arteriosus, stenting procedure.The 5.00 x 16mm synergy megatron was advanced for treatment.During the procedure, the stent delivery system balloon ruptured resulting in a lack of deployment of the stent.The stent remained im the left subclavian artery.The patient became severely cyanotic and was emergently transferred to the operating room for life saving intervention.The patient was returned to the operating room for removal of the retained stent and for vascular rep.
|
| |
|
Additional Manufacturer Narrative
|
|
B3 date of event was estimated based on reported event date of july 2025.
|
| |
|
Event or Problem Description
|
|
It was reported vis medsun (b)(4) that balloon rupture occurred requiring additional surgery.The patient presented for a right heart percutaneous, patent ductus arteriosus, stenting procedure.The 5.00 x 16mm synergy megatron was advanced for treatment.During the procedure, the stent delivery system balloon ruptured resulting in a lack of deployment of the stent.The stent remained im the left subclavian artery.The patient became severely cyanotic and was emergently transferred to the operating room for life saving intervention.The patient was returned to the operating room for removal of the retained stent and for vascular rep.
|
| |
|
Additional Manufacturer Narrative
|
|
B3 date of event was estimated based on reported event date of july 2025.Good faith effort attempts were made to try and retrieve additional details regarding the reported event, but further information was unable to be obtained.Investigation results:
device analysis findings:
the device wasnot be returned for analysis; therefore, a technical analysis could not be performed.Device history record review:
it was confirmed that this device met manufacturing specification prior to distribution and there no manufacturing deviations which could have contributed to the reported event.Labeling review:
review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.Risk review:
a risk review was performed, and it confirmed that the event was defined in the risk documentation and is recorded accordingly in the product record review.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion:
this investigation is assigned a most probable investigation conclusion code of cause traced to intentional off-label, unapproved, or contraindicated use as the use of this coronary stent to attempt to treat patent ductus arteriosus.Per instructions for use the synergy megatron is a coronary stent system, intended to treat coronary artery stenosis, however per information provided this synergy megatron device was selected treat patent ductus arteriosus which is an abnormal connection between the aorta and the pulmonary artery and not a coronary artery.
|
| |
|
Search Alerts/Recalls
|